These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 20397939)

  • 1. Prevention of HIV infection among injection drug users in resource-limited settings.
    Vlahov D; Robertson AM; Strathdee SA
    Clin Infect Dis; 2010 May; 50 Suppl 3(Suppl 3):S114-21. PubMed ID: 20397939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage.
    Mathers BM; Degenhardt L; Ali H; Wiessing L; Hickman M; Mattick RP; Myers B; Ambekar A; Strathdee SA;
    Lancet; 2010 Mar; 375(9719):1014-28. PubMed ID: 20189638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intravenous drug use and the spread of HIV; an international perspective].
    Meijerink H; van Crevel R; van der Ven AJ
    Ned Tijdschr Geneeskd; 2013; 157(21):A5690. PubMed ID: 23693006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Legal access to needles and syringes/needle exchange programmes versus HIV counselling and testing to prevent transmission of HIV among intravenous drug users: a comparative study of Denmark, Norway and Sweden.
    Amundsen EJ; Eskild A; Stigum H; Smith E; Aalen OO
    Eur J Public Health; 2003 Sep; 13(3):252-8. PubMed ID: 14533729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003.
    Emmanuelli J; Desenclos JC
    Addiction; 2005 Nov; 100(11):1690-700. PubMed ID: 16277629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards combination HIV prevention for injection drug users: addressing addictophobia, apathy and inattention.
    Strathdee SA; Shoptaw S; Dyer TP; Quan VM; Aramrattana A;
    Curr Opin HIV AIDS; 2012 Jul; 7(4):320-5. PubMed ID: 22498479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of needle exchange programs in HIV prevention.
    Vlahov D; Junge B
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):75-80. PubMed ID: 9722812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US.
    Taussig JA; Weinstein B; Burris S; Jones TS
    AIDS; 2000 Jun; 14 Suppl 1():S47-51. PubMed ID: 10981474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An analysis of optimal resource allocation for prevention of infection with human immunodeficiency virus (HIV) in injection drug users and non-users.
    Richter A; Brandeau ML; Owens DK
    Med Decis Making; 1999; 19(2):167-79. PubMed ID: 10231079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV, hepatitis B and sexual practices in the street-recruited injecting drug users of Calcutta: risk perception versus observed risks.
    Panda S; Chatterjee A; Bhattacharjee S; Ray B; Saha MK; Bhattacharya SK
    Int J STD AIDS; 1998 Apr; 9(4):214-8. PubMed ID: 9598748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States.
    Holtgrave DR; Pinkerton SD; Jones TS; Lurie P; Vlahov D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S133-8. PubMed ID: 9663636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple access to sterile syringes for injection drug users: vending machines, needle exchange programs and legal pharmacy sales in Marseille, France.
    Moatti JP; Vlahov D; Feroni I; Perrin V; Obadia Y
    Eur Addict Res; 2001 Mar; 7(1):40-5. PubMed ID: 11316925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study on the risk and its determinants of HIV transmission by syringe sharing among HIV-positive drug users].
    Bao Y; Zhang Y; Liang Y; Chen M; Sun J; Tan H
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Jun; 49(6):513-7. PubMed ID: 26310336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: a modeling analysis for Ukraine.
    Alistar SS; Owens DK; Brandeau ML
    PLoS Med; 2011 Mar; 8(3):e1000423. PubMed ID: 21390264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.
    Neaigus A; Zhao M; Gyarmathy VA; Cisek L; Friedman SR; Baxter RC
    J Urban Health; 2008 May; 85(3):309-22. PubMed ID: 18340537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Historical perspective on the use of bleach in HIV/AIDS prevention.
    Watters JK
    J Acquir Immune Defic Syndr (1988); 1994 Jul; 7(7):743-6. PubMed ID: 8207657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacist and pharmacy staff experiences with non-prescription (NP) sale of syringes and attitudes toward providing HIV prevention services for injection drug users (IDUs) in Providence, RI.
    Zaller N; Jeronimo A; Bratberg J; Case P; Rich JD
    J Urban Health; 2010 Dec; 87(6):942-53. PubMed ID: 21116724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The needle-borne HIV epidemic: causes and public health responses.
    Gostin L
    Behav Sci Law; 1991; 9(3):287-304. PubMed ID: 10148824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.